MGH Cancer Center — Boston, Massachusetts

MGH Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

MGH Cancer Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia (ALL).

Sponsors: Hoffmann-La Roche, MGH Institute of Health Professions, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MGH Cancer Center?

MGH Cancer Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MGH Cancer Center conducted?

MGH Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia (ALL).

Is MGH Cancer Center accredited by Crixeo Health?

MGH Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MGH Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.